Indian EMR startup HealthPlix scores $22M in Series C funding
15 Mar 2023
Preview
Source: mobihealthnews
Photo courtesy of HealthPlix
HealthPlix, a startup that runs one of India's biggest EMR platforms, has raised $22 million in a Series C funding round led by Avataar Venture Partners and SIG Venture Capital. The round included participation from its existing investors, including Lightspeed Venture Partners, JSW Ventures, Kalaari Capital, Chiratae Ventures, and Blacksoil Capital.
The HealthPlix EMR provides AI-powered clinical decision support at the point of care. It is currently used by over 10,000 doctors who are treating 2.5% of the Indian population. Since it was launched in 2014, HealthPlix has introduced more features to its platform, including Drug-to-Drug Interactions, mobile EMR, AI-powered SmartScan, and the Doctor Insights dashboard.
WHAT IT'S FOR
In a statement, the company said it will use its fresh funds to "ramp up doctor first product innovation, enhance the technology stack and scale user acquisition efforts." HealthPlix plans to raise its user base to around 25,000 doctors treating 15% of the Indian population by 2024.
"With these new funds, we aim to cater to around 200 million-250 million more patient lives in an 18-month time frame," added CEO and co-founder Sandeep Gudibanda.
MARKET SNAPSHOT
Last year, fellow Indian startup Eka Care also raised $15 million in Series A funding, the proceeds of which were intended to support its efforts to reach more doctor users. It claims to hold the biggest repository of health records in India with over 30 million records and more than 5,000 doctors using its EMR solutions.
Tags: HealthPlix, India, EMR
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.